BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 25913415)

  • 21. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.
    Mehrotra S; Britten CD; Chin S; Garrett-Mayer E; Cloud CA; Li M; Scurti G; Salem ML; Nelson MH; Thomas MB; Paulos CM; Salazar AM; Nishimura MI; Rubinstein MP; Li Z; Cole DJ
    J Hematol Oncol; 2017 Apr; 10(1):82. PubMed ID: 28388966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis.
    Coelho AV; de Moura RR; Kamada AJ; da Silva RC; Guimarães RL; Brandão LA; de Alencar LC; Crovella S
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals.
    Thiébaut R; Hejblum BP; Hocini H; Bonnabau H; Skinner J; Montes M; Lacabaratz C; Richert L; Palucka K; Banchereau J; Lévy Y
    Front Immunol; 2019; 10():874. PubMed ID: 31105698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
    Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
    J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment.
    van den Ham HJ; Cooper JD; Tomasik J; Bahn S; Aerts JL; Osterhaus ADME; Gruters RA; Andeweg AC;
    PLoS One; 2018; 13(2):e0192278. PubMed ID: 29389978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.
    Reis EC; da Silva LT; da Silva WC; Rios A; Duarte AJ; Oshiro TM; Crovella S; Pontillo A
    Hum Vaccin Immunother; 2018; 14(8):1995-2002. PubMed ID: 29641325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals.
    Connolly NC; Whiteside TL; Wilson C; Kondragunta V; Rinaldo CR; Riddler SA
    Clin Vaccine Immunol; 2008 Feb; 15(2):284-92. PubMed ID: 17942609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DC immunotherapy in HIV-1 infection induces a major blood transcriptome shift.
    de Goede AL; Andeweg AC; van den Ham HJ; Bijl MA; Zaaraoui-Boutahar F; van IJcken WF; Wilgenhof S; Aerts JL; Gruters RA; Osterhaus AD;
    Vaccine; 2015 Jun; 33(25):2922-9. PubMed ID: 25913415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cells and HIV infection; immunity with viral transmission versus compromised cellular immunity?
    Knight SC
    Immunobiology; 2001 Dec; 204(5):614-21. PubMed ID: 11846226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanochemistry-based immunotherapy for HIV-1.
    Lori F; Calarota SA; Lisziewicz J
    Curr Med Chem; 2007; 14(18):1911-9. PubMed ID: 17691933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology.
    Knight SC; Patterson S
    Annu Rev Immunol; 1997; 15():593-615. PubMed ID: 9143701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell-based human immunodeficiency virus vaccine.
    Rinaldo CR
    J Intern Med; 2009 Jan; 265(1):138-58. PubMed ID: 19093966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook.
    Mohamed H; Miller V; Jennings SR; Wigdahl B; Krebs FC
    J Immunol Res; 2020; 2020():9470102. PubMed ID: 32537473
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.